Using CRISPR Technology to Detect Antibiotic Resistance
Author Information
Author(s): Zhang Xuejiao, Huang Zhaojie, Zhang Yanxia, Wang Wen, Ye Zihong, Liang Pei, Sun Kai, Kang Wencheng, Tang Qiao, Yu Xiaoping
Primary Institution: Key Laboratory of Microbiological Metrology, Measurement & Bio-product Quality Security, State Administration for Market Regulation, College of Life Science, China Jiliang University
Hypothesis
The study explores the potential of CRISPR technology for detecting antibiotic resistance genes and antibiotic molecules.
Conclusion
CRISPR/Cas systems show promise for rapid and sensitive detection of antibiotic resistance and antibiotic molecules.
Supporting Evidence
- CRISPR technology can detect both nucleic acid and non-nucleic acid targets.
- Current methods show high sensitivity and specificity for antibiotic detection.
- CRISPR/Cas systems can be adapted for rapid point-of-care diagnostics.
Takeaway
Scientists are using a special tool called CRISPR to find out if bacteria are resistant to antibiotics, which helps keep us safe from infections.
Methodology
The review discusses various CRISPR/Cas systems and their applications in detecting nucleic acid and non-nucleic acid targets related to antibiotic resistance.
Potential Biases
Potential for false positives due to off-target effects in CRISPR detection.
Limitations
Current CRISPR-based detection methods often require amplification techniques, which can introduce contamination risks and increase detection time.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website